Skip to main content
Year archive

AMPLIA THERAPEUTICS LIMITED — 2021 filings

All 89 regulatory filings released by AMPLIA THERAPEUTICS LIMITED (ATX) in 2021, sourced directly from the official regulator.

89 Filings
2021 Period
2021 filings (89)
Filing Released Lang
Change in substantial holding 3 pages 141.7KB
Major Shareholding Notification
2021-12-22 English
Change in substantial holding 3 pages 145.4KB
Major Shareholding Notification
2021-12-21 English
Application for quotation of securities - ATX 6 pages 27.8KB
Capital/Financing Update
2021-12-21 English
Application for quotation of securities - ATX 6 pages 27.8KB
Share Issue/Capital Change
2021-12-21 English
Proposed issue of securities - ATX 5 pages 27.8KB
Capital/Financing Update
2021-12-20 English
App 3Y - Change of Directors Interest Notice - Dr. W. Tong 4 pages 290.7KB
Director's Dealing
2021-12-20 English
App 3Y - Change of Director's Interest - Dr. John Lambert 4 pages 303.8KB
Director's Dealing
2021-12-20 English
App 3Y - Change of Director's Interest - Dr. Robert Peach 4 pages 289.9KB
Director's Dealing
2021-12-20 English
App 3Y - Change of Director's Interest - Dr. Chris Burns 3 pages 285.9KB
Director's Dealing
2021-12-20 English
App 3Y - Change of Director's Interest - Mrs Jane Bell 4 pages 330.1KB
Director's Dealing
2021-12-20 English
Update - Application for quotation of securities - ATX 7 pages 29.5KB
Capital/Financing Update
2021-12-19 English
Results of Extraordinary General Meeting 2 pages 194.3KB
Declaration of Voting Results & Voting Rights Announcements
2021-12-16 English
Amplia Provides Updated Investor Presentation 27 pages 3.1MB
Investor Presentation
2021-12-15 English
Update - Application for quotation of securities - ATX 7 pages 29.8KB
Capital/Financing Update
2021-12-14 English
Change in substantial holding 3 pages 207.6KB
Regulatory Filings
2021-12-14 English
Update - Proposed issue of securities - ATX 9 pages 39.0KB
Capital/Financing Update
2021-12-13 English
Entitlement Offer Completed 2 pages 111.4KB
Capital/Financing Update
2021-12-09 English
Amplia Awarded $2.1M R&D Cash Flow Loan 2 pages 136.7KB
Capital/Financing Update
2021-12-01 English
App 4D and Financial Report Half Year ended 30 Sep 2021 22 pages 617.9KB
Interim / Quarterly Report
2021-11-23 English
Notice of Extraordinary General Meeting - 17 Dec 2021 20 pages 542.6KB
Proxy Solicitation & Information Statement
2021-11-18 English
Summary Results - Successful Phase 1 Clinical Trial AMP945 2 pages 170.7KB
Regulatory Filings
2021-11-17 English
Inhibition of FAK by AMP945 in Phase 1 Clinical Trial 2 pages 140.0KB
Regulatory Filings
2021-11-16 English
Becoming a substantial holder 3 pages 82.2KB
Major Shareholding Notification
2021-11-15 English
Application for quotation of securities - ATX 6 pages 27.8KB
Share Issue/Capital Change
2021-11-14 English
Change in substantial holding 3 pages 144.7KB
Major Shareholding Notification
2021-11-14 English
Application for quotation of securities - ATX 6 pages 28.2KB
Share Issue/Capital Change
2021-11-14 English
Application for quotation of securities - ATX 6 pages 28.1KB
Share Issue/Capital Change
2021-11-11 English
Blueflag Holding - Change of Interest of Substantial Holder 2 pages 133.8KB
Regulatory Filings
2021-11-11 English
Section 708A Cleansing Notice - Share Placement 1 p
Capital/Financing Update
2021-11-11 English
Placement and Underwritten Entitlement Offer to Raise $12.4m 5 pages 243.7KB
Capital/Financing Update
2021-11-07 English
Entitlement Offer Prospectus 51 pages 976.9KB
Capital/Financing Update
2021-11-07 English
Capital Raising Investor Presentation 41 pages 2.2MB
Capital/Financing Update
2021-11-07 English
Proposed issue of securities - ATX 7 pages 33.6KB
Capital/Financing Update
2021-11-07 English
Proposed issue of securities - ATX 9 pages 39.4KB
Capital/Financing Update
2021-11-07 English
Trading Halt 2 pages 168.0KB
Capital/Financing Update
2021-11-03 English
Amplia and CRUK agree to Amend Licence Terms - AMP886 1
Capital/Financing Update
2021-11-03 English
Quarterly Activities and Cashflow Reports - Sep 2021 Qtr 8 pages 356.4KB
Interim / Quarterly Report
2021-10-26 English
Amplia Appoints New Oncology Clinical Advisor 2 pages 136.2KB
Board/Management Information
2021-10-25 English
Amplia Provides Updated Investor Presentation 35 pages 2.5MB
Investor Presentation
2021-10-18 English
Amplia Receives $1.1m R&D Tax Incentive 1 page 107.
Regulatory Filings
2021-10-13 English
Amplia Appoints New Chief Financial Officer 1 page
Board/Management Information
2021-09-30 English
New Garvan Publication Supports Amplia Phase 2 Design 2 pages 165.3KB
Regulatory Filings
2021-09-29 English
Proactive Investors Lifesciences Webinar Presentation 15 pages 1.2MB
Investor Presentation
2021-09-27 English
Amplia to Present at Proactive Investor Lifesciences Webinar 1
Investor Presentation
2021-09-26 English
Updated Investor Presentation 34 pages 2.7MB
Investor Presentation
2021-09-14 English
Phase 2 Trial in First-Line Pancreatic Cancer Patients 2 pages 140.1KB
Capital/Financing Update
2021-09-14 English
Change of Director's Interest Notice - Jane Bell 3 pages 284.4KB
Director's Dealing
2021-09-05 English
AGM - Chief Executive Officer's Presentatioin 14 pages 1.4MB
AGM Information
2021-08-26 English
Results of Annual General Meeting 2 pages 156.1KB
Declaration of Voting Results & Voting Rights Announcements
2021-08-26 English
Annual General Meeting Arrangements 1 page 109.9KB
AGM Information
2021-08-19 English
Quarterly Activities and Cashflow Reports and Presentation 29 pages 2.3MB
Interim / Quarterly Report
2021-07-27 English
Shareholder Update and Presentation 1 page 106.2KB
Investor Presentation
2021-07-25 English
Notice of Annual General Meeting/Proxy Form 16 pages 491.1KB
AGM Information
2021-07-22 English
Annual Report to Shareholders - YE 31 March 2021 50 pages 1.3MB
Annual Report
2021-07-22 English
2021 Corporate Governance Statement 16 pages 377.3KB
Governance Information
2021-07-22 English
App 4G - Key to Corporate Governance Disclosures 15 pages 419.9KB
Regulatory Filings
2021-07-22 English
Results from Successful Phase 1 Clinical Trial of AMP945 2 pages 168.3KB
Regulatory Filings
2021-07-20 English
Financial Report YE 31 March 2021 - Audited 46 pages 1.3MB
Annual Report
2021-06-28 English
Amplia and Garvan Enter Into Collaboration Agreement 2 pages 115.7KB
Capital/Financing Update
2021-06-27 English
Annual General Meeting to be Held 27 August 2021 1
AGM Information
2021-06-24 English
Change of Director's Interest - Dr. Lambert Exercise Options 4 pages 303.0KB
Director's Dealing
2021-06-07 English
Application for quotation of securities - ATX 6 pages 27.7KB
Share Issue/Capital Change
2021-06-06 English
Application for quotation of securities - ATX 6 pages 28.2KB
Share Issue/Capital Change
2021-06-06 English
AMP945 Improves Survival in Pacnreatic Cancer Model 2 pages 177.1KB
Regulatory Filings
2021-06-01 English
Application for Quotation of Shares - Options Exercised 16 pages 263.7KB
Share Issue/Capital Change
2021-05-31 English
App 4E - Preliminary Final Report YE 31 March 2021 10 pages 341.2KB
Interim / Quarterly Report
2021-05-30 English
Change in substantial holding 3 pages 250.1KB
Report Publication Announcement
2021-05-10 English
Appendix 3G - Notification of Issue of Securties - Options 13 pages 400.5KB
Capital/Financing Update
2021-05-09 English
Appendix 2A - Application for Quotation of Shares 16 pages 420.7KB
Capital/Financing Update
2021-05-09 English
Section 708A Cleansing Notice - Share Placement 1 p
Capital/Financing Update
2021-05-09 English
Amplia Announces $3.8m Share Placement 1 page 118.2
Capital/Financing Update
2021-05-03 English
Proposed issue of Securities - ATX 5 pages 28.4KB
Capital/Financing Update
2021-05-03 English
Trading Halt 2 pages 201.3KB
Capital/Financing Update
2021-04-29 English
Quarterly Report and Shareholder Update 32 pages 2.3MB
Interim / Quarterly Report
2021-04-27 English
Preclinical Data Support Developmnt AMP945 Pancreatic Cancer 2 pages 187.9KB
Capital/Financing Update
2021-04-27 English
Shareholder Update and Presentation 1 page 105.9KB
Investor Presentation
2021-04-21 English
Initial Director's Interest Notice - Jane Bell 3 pages 264.3KB
Director's Dealing
2021-04-21 English
ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH 2 pages 194.1KB
Regulatory Filings
2021-04-19 English
Amplia Completes Dosing in Phase 1 Clinical Study of AMP945 1
Regulatory Filings
2021-04-14 English
Amplia Appoints New Non-Executive Director 1 page 1
Board/Management Information
2021-04-11 English
Change of Registered Office and Principal Place of Business 1
Regulatory Filings
2021-03-24 English
Appendix 2A - Exercise of Options 16 pages 421.1KB
Regulatory Filings
2021-03-23 English
Amplia and Garvan Institute Enter Collaboration Agreement 2 pages 115.3KB
Regulatory Filings
2021-03-17 English
Amplia Completes Single Dose Study of AMP945 1 page
Regulatory Filings
2021-03-16 English
Amplia Initiates Multiple Dose Study of AMP945 1 pa
Regulatory Filings
2021-02-16 English
Appendix 2A - Exercise of Options 16 pages 421.1KB
Share Issue/Capital Change
2021-02-15 English
Investor Update - February 2021 29 pages 1.9MB
Investor Presentation
2021-02-10 English
Quarterly Activities and Cashflow Reports - Dec 2020 Qtr 7 pages 226.2KB
Interim / Quarterly Report
2021-01-27 English
Appendix 2A - Exercise of Options 16 pages 270.5KB
Capital/Financing Update
2021-01-10 English